Global Cardiovascular Medical Lasers Market Comprehensive Study: Forecasted Market Size And Growth Rate | Boston Scientific Corporation, Cardiovascular Systems Inc., AngioDynamics Inc., Koninklijke Philips N.V., RA Medical Systems Inc., Abbott Laboratorie

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033

The Business Research Company offers in-depth market insights through Cardiovascular Medical Lasers Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The cardiovascular medical lasers market size has grown exponentially in recent years. It will grow from $0.21 billion in 2023 to $0.31 billion in 2024 at a compound annual growth rate (CAGR) of 46.4%. The growth in the historic period can be attributed to growing demand for minimally invasive cardiovascular procedures, rising prevalence of cardiovascular diseases, rising disposable incomes, growing adoption of telemedicine in cardiology, .

The cardiovascular medical lasers market size is expected to see exponential growth in the next few years. It will grow to $1.25 billion in 2028 at a compound annual growth rate (CAGR) of 41.5%. The growth in the forecast period can be attributed to advanced robotics, cardiovascular research, aging population, personalized cardiovascular care, expansion of interventional cardiology. Major trends in the forecast period include advanced laser fiber technology, ai-powered telehealth, smart laser systems, laser-induced regeneration, sustainable laser technologies, integration of advanced imaging.

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=3368&type=smp

Market Segmentation:
The cardiovascular medical lasers market covered in this report is segmented by type into excimer lasers and carbon dioxide laser. The carbon dioxide laser aids in the removal of thin layers of skin while causing minimal damage to surrounding structures. These are used in various applications such as laser vascular anastomosis, transmyocardial laser revascularization, and laser angioplasty for peripheral arterial diseases that are used by end users such as hospitals, specialty clinics, and ambulatory surgery centers.

Major Driver - Rising Cardiovascular Diseases Drive Demand For Cardiovascular Medical Lasers
The rising prevalence of cardiovascular diseases is expected to drive the cardiovascular medical laser market. The increased prevalence of cardiovascular diseases can be attributed to the increase in smoking, physical inactivity, and an unhealthy diet. For instance, in May 2023, according to the Centers for Disease Control and Prevention, a US-based public agency, coronary artery disease (CAD) was responsible for killing 375,476 people in 2021, and about 1 in 20 adults age 20 and older had CAD. In addition, about 2 in 10 deaths from CAD happen to adults less than 65 years old. Therefore, the increasing prevalence of cardiovascular diseases is expected to drive the growth of the cardiovascular medical lasers market.

Competitive Landscape:
Major companies operating in the cardiovascular medical lasers market include Boston Scientific Corporation, Cardiovascular Systems Inc., AngioDynamics Inc., Koninklijke Philips N.V., RA Medical Systems Inc., Abbott Laboratories Inc., Alma Lasers Inc., B. Braun Melsungen AG, Bausch + Lomb Incorporated, Biolase Inc., Candela Medical Corporation, Cutera Inc., DEKA Research & Development Corporation, Edwards Lifesciences Corporation, EUFOTON S.P.A., Fotona d.d., Gigaa Laser Group, IRIDEX Corporation, Lumenis Ltd., Medtronic Inc., Novartis AG, PhotoMedex Inc., Quanta System S.p.A, Sciton Inc., Stryker Corporation, Terumo Corporation, TransEnterix Inc., Vascular Solutions Inc., Zimmer Biomet Holdings Inc.

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/cardiovascular-medical-lasers-global-market-report

Top Trend - Cardiovascular Medical Laser Manufacturers Invest In New Technologies For Faster And More Efficient Treatment
Cardiovascular medical laser manufacturers are constantly investing in technologies for faster diagnosis and efficient treatment of heart conditions. Areas of technological advances include new wavelengths, more rugged setups, lower-cost systems, and other advancements are being combined with minimally invasive techniques. FDA cleared Ra Medical's vascular products including cardiovascular lasers that can be used to treat peripheral arteries and veins. The laser works at 308-nanometer wavelength, which breaks chemical bonds and decomposes the blockage into its part, thereby reducing the risk for the patient.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Cardiovascular Medical Lasers Market Characteristics
3. Cardiovascular Medical Lasers Market Trends And Strategies
4. Cardiovascular Medical Lasers Market - Macro Economic Scenario
5. Cardiovascular Medical Lasers Market Size And Growth
…..
27. Cardiovascular Medical Lasers Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

This release was published on openPR.